These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 26923011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms.
    Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, Herman M, Yu WH, Luchsinger JA, Wadzinski B, Duff KE, Takashima A.
    J Neurosci; 2007 Dec 12; 27(50):13635-48. PubMed ID: 18077675
    [Abstract] [Full Text] [Related]

  • 5. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.
    Li SQ, Yu Y, Han JZ, Wang D, Liu J, Qian F, Fan GH, Bucala R, Ye RD.
    J Neuroinflammation; 2015 Sep 17; 12():177. PubMed ID: 26382037
    [Abstract] [Full Text] [Related]

  • 6. NADPH oxidase contributes to streptozotocin-induced neurodegeneration.
    Ravelli KG, Rosário BDA, Vasconcelos AR, Scavone C, Camarini R, Hernandes MS, Britto LR.
    Neuroscience; 2017 Sep 01; 358():227-237. PubMed ID: 28687315
    [Abstract] [Full Text] [Related]

  • 7. Pyrroloquinoline quinone ameliorates oxidative stress and lipid peroxidation in the brain of streptozotocin-induced diabetic mice.
    Kumar N, Kar A.
    Can J Physiol Pharmacol; 2015 Jan 01; 93(1):71-9. PubMed ID: 25474723
    [Abstract] [Full Text] [Related]

  • 8. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
    de la Monte SM, Tong M, Schiano I, Didsbury J.
    J Alzheimers Dis; 2017 Jan 01; 55(2):849-864. PubMed ID: 27802237
    [Abstract] [Full Text] [Related]

  • 9. Learning Deficits Accompanied by Microglial Proliferation After the Long-Term Post-Injection of Alzheimer's Disease Brain Extract in Mouse Brains.
    Hayashi T, Shimonaka S, Elahi M, Matsumoto SE, Ishiguro K, Takanashi M, Hattori N, Motoi Y.
    J Alzheimers Dis; 2021 Jan 01; 79(4):1701-1711. PubMed ID: 33459716
    [Abstract] [Full Text] [Related]

  • 10. Partial reduction of microglia does not affect tau pathology in aged mice.
    Bennett RE, Bryant A, Hu M, Robbins AB, Hopp SC, Hyman BT.
    J Neuroinflammation; 2018 Nov 09; 15(1):311. PubMed ID: 30413160
    [Abstract] [Full Text] [Related]

  • 11. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
    Gratuze M, Julien J, Petry FR, Morin F, Planel E.
    Sci Rep; 2017 Apr 12; 7():46359. PubMed ID: 28402338
    [Abstract] [Full Text] [Related]

  • 12. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S.
    J Alzheimers Dis; 2010 Apr 12; 19(2):691-704. PubMed ID: 20110613
    [Abstract] [Full Text] [Related]

  • 13. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A, Hunter J, Quadri Z, Zamudio F, Rocha-Rangel PV, Chan D, Kesarwani A, Nash K, Lee DC, Morgan D, Gordon MN, Selenica MB.
    Front Immunol; 2020 Apr 12; 11():997. PubMed ID: 32508844
    [Abstract] [Full Text] [Related]

  • 14. Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model.
    Shivananjappa MM, Muralidhara.
    Reprod Biomed Online; 2012 May 12; 24(5):558-66. PubMed ID: 22414371
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of TREM2 Ameliorates Neuroinflammatory Responses and Improves Cognitive Deficits Triggered by Surgical Trauma in Appswe/PS1dE9 Mice.
    Jiang Y, Li Z, Ma H, Cao X, Liu F, Tian A, Sun X, Li X, Wang J.
    Cell Physiol Biochem; 2018 May 12; 46(4):1398-1411. PubMed ID: 29689568
    [Abstract] [Full Text] [Related]

  • 16. Distinct contributions of hyperglycemia and high-fat feeding in metabolic syndrome-induced neuroinflammation.
    Wanrooy BJ, Kumar KP, Wen SW, Qin CX, Ritchie RH, Wong CHY.
    J Neuroinflammation; 2018 Oct 22; 15(1):293. PubMed ID: 30348168
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of pterostilbene in a streptozotocin-induced mouse model of Alzheimer's disease by targeting monoamine oxidase B.
    Li Q, Li X, Tian B, Chen L.
    J Appl Toxicol; 2022 Nov 22; 42(11):1777-1786. PubMed ID: 35665945
    [Abstract] [Full Text] [Related]

  • 18. Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
    Tahirovic I, Sofic E, Sapcanin A, Gavrankapetanovic I, Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z, Hoyer S, Riederer P.
    Neurochem Res; 2007 Oct 22; 32(10):1709-17. PubMed ID: 17605105
    [Abstract] [Full Text] [Related]

  • 19. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
    Ding Y, Liu H, Cen M, Tao Y, Lai C, Tang Z.
    Neurochem Res; 2021 Feb 22; 46(2):265-275. PubMed ID: 33140268
    [Abstract] [Full Text] [Related]

  • 20. Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease.
    Ke YD, Delerue F, Gladbach A, Götz J, Ittner LM.
    PLoS One; 2009 Nov 19; 4(11):e7917. PubMed ID: 19936237
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.